A Path Forward to Save American Bio-Medical Research talkingpointsmemo.com/edblog/a-pat...
A Path Forward to Save American Bio-Medical Research
Over the past four months, I’ve spoken to dozens of biomedical researchers...
talkingpointsmemo.com
May 18, 2025 at 4:52 PM
A Path Forward to Save American Bio-Medical Research talkingpointsmemo.com/edblog/a-pat...
Reposted by Steve Davidson
Published an op-ed for @cnn.com: “Nobel laureate: I owe America my success. Today, its scientific future is in danger.”
A personal reflection on what’s at stake as science funding gets slashed. I’d be grateful if you could amplify both in and beyond the science world.
www.cnn.com/2025/04/09/h...
A personal reflection on what’s at stake as science funding gets slashed. I’d be grateful if you could amplify both in and beyond the science world.
www.cnn.com/2025/04/09/h...
Nobel laureate: I owe America my success. Today, its scientific future is in danger | CNN
Dr. Ardem Patapoutian says he watches “with deep sadness as the United States’ remarkable scientific enterprise, which took generations of hard work and national investment to build, faces a concerted...
www.cnn.com
April 9, 2025 at 11:30 AM
Published an op-ed for @cnn.com: “Nobel laureate: I owe America my success. Today, its scientific future is in danger.”
A personal reflection on what’s at stake as science funding gets slashed. I’d be grateful if you could amplify both in and beyond the science world.
www.cnn.com/2025/04/09/h...
A personal reflection on what’s at stake as science funding gets slashed. I’d be grateful if you could amplify both in and beyond the science world.
www.cnn.com/2025/04/09/h...
Excellent use of peripherally restricted targeting for analgesia and limiting unwanted central effects. rdcu.be/efdWs
A cryptic pocket in CB1 drives peripheral and functional selectivity
Nature - A peripherally restricted CB1 agonist (VIP36) targeting a cryptic receptor pocket was developed, showing high efficacy in mouse pain models with minimal side effects and tolerance,...
rdcu.be
March 26, 2025 at 6:14 PM
Excellent use of peripherally restricted targeting for analgesia and limiting unwanted central effects. rdcu.be/efdWs
Reposted by Steve Davidson
NIH indirects case update:
Hearing ongoing now, and I'll try to live tweet some notable exchanges.
Prior to more detailed arguments, Judge Kelley starts off with a few point questions to both sides:
(I'm paraphrasing here)
Hearing ongoing now, and I'll try to live tweet some notable exchanges.
Prior to more detailed arguments, Judge Kelley starts off with a few point questions to both sides:
(I'm paraphrasing here)
February 21, 2025 at 3:19 PM
NIH indirects case update:
Hearing ongoing now, and I'll try to live tweet some notable exchanges.
Prior to more detailed arguments, Judge Kelley starts off with a few point questions to both sides:
(I'm paraphrasing here)
Hearing ongoing now, and I'll try to live tweet some notable exchanges.
Prior to more detailed arguments, Judge Kelley starts off with a few point questions to both sides:
(I'm paraphrasing here)
Oh damn NPI just got rescheduled
February 18, 2025 at 7:58 PM
Oh damn NPI just got rescheduled
Don’t bother trying to find latent pruritic priming after dry skin; mc903, imiquimod…what’re you hiding?
Acetone–Ether–Water Mouse Model of Persistent Itch Fully Resolves Without Latent Pruritic or Cross-Modality Priming
Hyperalgesic priming is a model of the transition from acute to chronic pain. Whether a similar mechanism exists for “pruritic priming” of itch is unknown. Here, we tested the hypothesis that itchy sk...
doi.org
February 14, 2025 at 1:22 AM
Don’t bother trying to find latent pruritic priming after dry skin; mc903, imiquimod…what’re you hiding?
State attorneys general and University council activate!
February 9, 2025 at 12:14 AM
State attorneys general and University council activate!
Reposted by Steve Davidson
(1/3) Dr. Kara Margolis, director of the @nyupainresearch.bsky.social
and associate professor of molecular pathobiology, co-authored two important studies published this week – one in Gastroenterology and one in Molecular Psychiatry – showing the connection between serotonin in the gut,
and associate professor of molecular pathobiology, co-authored two important studies published this week – one in Gastroenterology and one in Molecular Psychiatry – showing the connection between serotonin in the gut,
December 16, 2024 at 6:42 PM
(1/3) Dr. Kara Margolis, director of the @nyupainresearch.bsky.social
and associate professor of molecular pathobiology, co-authored two important studies published this week – one in Gastroenterology and one in Molecular Psychiatry – showing the connection between serotonin in the gut,
and associate professor of molecular pathobiology, co-authored two important studies published this week – one in Gastroenterology and one in Molecular Psychiatry – showing the connection between serotonin in the gut,
Reposted by Steve Davidson
(2/3) mood disorders, and digestive issues. The studies show that increasing serotonin in the lining of the gut improves anxiety and depression, and that antidepressants during pregnancy increase the risk for digestive issues in children.
December 16, 2024 at 6:41 PM
(2/3) mood disorders, and digestive issues. The studies show that increasing serotonin in the lining of the gut improves anxiety and depression, and that antidepressants during pregnancy increase the risk for digestive issues in children.
Reposted by Steve Davidson
(3/3)Together, the studies reveal a promising avenue for future research: targeting antidepressants selectively to the gut as a new and potentially safer way to treat mood disorders.
Read more about both studies: nyu.edu/about/news-p... & nature.com/articles/s41... #DGBI #BrainGut
Read more about both studies: nyu.edu/about/news-p... & nature.com/articles/s41... #DGBI #BrainGut
Scientists Find Promising New Target for Antidepressants—In the Gut
Increasing serotonin in the lining of the gut improves anxiety and depression in animal studies and may offer new therapeutic approach during pregnancy to avoid newfound risk of digestive issues in ch...
nyu.edu
December 16, 2024 at 6:40 PM
(3/3)Together, the studies reveal a promising avenue for future research: targeting antidepressants selectively to the gut as a new and potentially safer way to treat mood disorders.
Read more about both studies: nyu.edu/about/news-p... & nature.com/articles/s41... #DGBI #BrainGut
Read more about both studies: nyu.edu/about/news-p... & nature.com/articles/s41... #DGBI #BrainGut